Neuroendocrine Tumor

While the incidence rate of neuroendocrine tumours has been increasing, the survival rate has not. Therefore, there is a great need for state-of-the-art research and new treatment protocols. The chapters in this book contribute to that debate and will be required reading for both researchers and hea...

Full description

Bibliographic Details
Main Author: Lowell, Anthony
Format: eBook
Language:English
Published: IntechOpen 2012
Subjects:
Online Access:
Collection: Directory of Open Access Books - Collection details see MPG.ReNa
LEADER 01824nma a2200289 u 4500
001 EB001990526
003 EBX01000000000000001153428
005 00000000000000.0
007 cr|||||||||||||||||||||
008 210512 ||| eng
020 |a 9789535170082 
020 |a 9789535106531 
020 |a 1665 
100 1 |a Lowell, Anthony 
245 0 0 |a Neuroendocrine Tumor  |h Elektronische Ressource 
260 |b IntechOpen  |c 2012 
300 |a 1 electronic resource (70 p.) 
653 |a Oncology / bicssc 
653 |a Oncology 
700 1 |a Lowell, Anthony 
041 0 7 |a eng  |2 ISO 639-2 
989 |b DOAB  |a Directory of Open Access Books 
500 |a Creative Commons (cc), https://creativecommons.org/licenses/by/3.0/ 
028 5 0 |a 10.5772/1665 
856 4 0 |u https://mts.intechopen.com/storage/books/1188/authors_book/authors_book.pdf  |7 0  |x Verlag  |3 Volltext 
856 4 2 |u https://directory.doabooks.org/handle/20.500.12854/66122  |z DOAB: description of the publication 
520 |a While the incidence rate of neuroendocrine tumours has been increasing, the survival rate has not. Therefore, there is a great need for state-of-the-art research and new treatment protocols. The chapters in this book contribute to that debate and will be required reading for both researchers and healthcare practitioners, as it offers both overviews of the condition and specialized contributions. Topics covered include the association between chronic inflammation and gastroenteropancreatic neuroendocrine tumours, or GEP-NETs. GEP-NETs are also addressed in a chapter on their circulating markers, which can help in diagnosing this hard to detect condition. One chapter covers the role of Chromogranin A, while another addresses the diagnosis and management of neuroendocrine carcinomas in cases where the primary site is unknown.